April 26 (Reuters) - Eli Lilly (NYSE:LLY) and Co LLY.N :
* U.S. COURT OF APPEALS RULES IN FAVOR OF LILLY IN ALIMTA VITAMIN REGIMEN PATENT LAWSUIT
* ELI LILLY AND CO - IF PATENT IS ULTIMATELY UPHELD THROUGH ALL REMAINING CHALLENGES, ALIMTA WOULD MAINTAIN U.S. EXCLUSIVITY UNTIL MAY 2022
* ELI LILLY - U.S. COURT OF APPEALS DECISION UPHOLDS AN OCTOBER 2017 DECISION BY PATENT TRIAL AND APPEAL BOARD OF U.S. PATENT AND TRADEMARK OFFICE
* ELI LILLY AND CO - DR. REDDY'S LABORATORIES AND HOSPIRA HAVE APPEALED DISTRICT COURT'S DECISIONS
* ELI LILLY AND CO - HEARING ON THOSE APPEALS IS SCHEDULED FOR JUNE 2019.